A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor
PHASE2CompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
July 31, 1996
Study Completion Date
May 31, 2000
Conditions
NephroblastomaNeuroblastoma
Interventions
DRUG
IFN-alpha with retinoic acid
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001509 - A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor | Biotech Hunter | Biotech Hunter